-
Trump says Iran meeting set in Qatar, despite uncertainty
-
Paraguay shock Germany as Brazil, Morocco advance at World Cup
-
Morocco down Netherlands to reach World Cup last 16
-
NASA robot mission aiming to rescue space telescope
-
Asian stocks unable to track Wall St higher, yen holds at 40-year low
-
Mouse-that-roared Paraguay savors World Cup win over Germany
-
'We came from nothing': DR Congo dreams of England World Cup upset
-
Taiwan's ageing seaweed harvesters hope younger women wade in
-
Peruvian political heir Fujimori wins presidency
-
Key Venezuela port opens with US aid, as burials begin
-
What to expect as EU small parcel levy kicks in
-
Ambitious Japan search for answers after World Cup exit
-
Nagelsmann says won't 'run away' after Germany World Cup exit
-
How NATO will try to keep Trump happy at Ankara summit
-
Paraguay coach salutes 'extraordinary' World Cup win over Germany
-
Ultra-wealthy Chinese exile in New York sentenced to 30 years for fraud
-
Japan fans stunned as Brazil end their World Cup dream
-
Years on, families bury 68 Indigenous victims of Guatemala civil war
-
'Powerhouse' Haaland leads by example at World Cup: Norway coach Solbakken
-
'Deliberate' Monaco explosion wounds Ukrainian oligarch
-
Sadness and joy as breakaway Catholic group nears schism
-
Paraguay shock Germany, Brazil advance at World Cup
-
Germany dumped out by Paraguay in seismic World Cup shock
-
'I recognized her ring': identifying Venezuela's dead in a makeshift morgue
-
More than 1,000 drones detected since start of World Cup: FBI
-
Tuchel defensive headache as England ready for DR Congo clash
-
Extreme heat warning issued for World Cup host Kansas City
-
US reopens Venezuela port as quake deaths top 1,700
-
Bloodied but unbowed: Sinner, Djokovic survive Wimbledon scares
-
Coach says Japan getting closer to World Cup glory despite defeat
-
Djokovic battles past Wu in 'challenging' Wimbledon first round
-
NBA Grizzlies deal Morant to Portland: report
-
World Bank drops climate finance targets in renewed action plan
-
Sweden ready for 'game of our lives' in France World Cup clash
-
Ancelotti says never doubted 'suffering' Brazil would score
-
MLS Chicago Fire announce signing of Poland's Lewandowski
-
Venezuela's quake-hit La Guaira port 'operational': US military
-
Tech rebound lifts Dow to record, yen hits 40-year low against dollar
-
Martinelli late show as Brazil down Japan to reach World Cup last 16
-
US Supreme Court rules on dragnet searches of cellphone location data
-
Madueke says he can be England's World Cup game-changer
-
South Korea fans target coach Hong with boos as World Cup squad returns
-
Switzerland returns famed Benin Bronzes to Nigeria
-
Vaughan calls for England change after Stokes bows out with defeat
-
Last-gasp Brazil down Japan to reach World Cup 16
-
Europe's deadly heatwave scorches east, Slovakia hits record
-
Spain confident despite World Cup injury setbacks, says Llorente
-
French Open champ Andreeva sails into Wimbledon second round
-
Martinelli scores in 95th minute to send Brazil into World Cup last 16
-
Shooter in custody dispute kills six at German family shelter
Court to hear lawsuit seeking to ban abortion pill in US
A Texas judge favored by anti-abortion activists will hear arguments Wednesday in an unprecedented challenge to the legality of a widely-used abortion pill.
US District Court Judge Matthew Kacsmaryk announced Monday the hearing on a lawsuit alleging the US Food and Drug Administration (FDA) should never have approved the "dangerous" prescription drug Mifepristone in 2000.
Mifepristone, one component of a two-drug regimen used for medication abortion, has been used by an estimated 5.6 million women to terminate pregnancies since its approval, according to the FDA.
It is can be used in the United States up to 10 weeks of pregnancy.
The pro-abortion rights Guttmacher Institute estimates that more than half of all abortions involve the use of mifepristone.
But the Alliance Defending Freedom, a Christian advocacy group, sued the FDA saying its approval "disavow(ed)" science, "ignored" potential health impacts and "disregarded" the complications that can arise with using mifepristone.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Galvanized by the Supreme Court's ruling in June that overturned the constitutional right to an abortion, abortion opponents have now set their sights on obtaining prohibitions on mifepristone.
Already the treatment has been halted in some 15 states which have banned all abortion since the 2022 Supreme Court decision.
The Texas suit seeks to block it nationally by overturning the FDA's approval of the drug.
The FDA has urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
Kacsmaryk was targeted by the plaintiffs to hear the case due to his deep conservative Christian beliefs and previous anti-abortion stance.
He had been expected since February 24 to issue a ruling in the case, which asks him to suspend the FDA's approval of the drug while the lawsuit proceeds.
Apparently fearing protestors descending on the courthouse in Amarillo, Texas, Kacsmaryk originally sought to keep the hearing secret until the last minute, but it leaked to media.
If he does order the suspension, it could leave pregnant women with the alternative of using only misoprostol, the second pill in the medication abortion treatment.
But using misoprostol alone is more physically traumatic than the two-pill procedure, and some fear doctors might be unwilling to prescribe it alone.
If mifepristone is banned, "access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
E.Rodriguez--AT